$42.86
-0.17 (-0.38%)
Performance
1D
—
1W
—
1M
—
3M
+44.90%
6M
+37.77%
1Y
+22.49%
YTD
+46.38%
Open$43.02
Previous Close$43.03
Day High$44.65
Day Low$42.26
52W High$44.00
52W Low$25.28
Volume—
Avg Volume2.53M
Market Cap6.54B
P/E Ratio14.62
EPS$2.78
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$30.02
Above
SMA 200
$32.89
Above
RSI (14)
46.3
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+45.6% upside
Current
$42.86
$42.86
Target
$62.39
$62.39
$43.17
$62.39 avg
$72.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 582.44M | 1.04B | 1.08B |
| Net Income | 422.62M | 129.57M | 136.18M |
| Profit Margin | 72.6% | 12.5% | 12.7% |
| EBITDA | 126.81M | 169.61M | 170.48M |
| Free Cash Flow | — | 110.01M | 140.89M |
| Rev Growth | +504.9% | +16.6% | +24.3% |
| Debt/Equity | 1.10 | 0.33 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |